Compare TNL & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TNL | TFX |
|---|---|---|
| Founded | 1990 | 1943 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 5.3B |
| IPO Year | 2006 | 1994 |
| Metric | TNL | TFX |
|---|---|---|
| Price | $63.54 | $130.17 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 8 |
| Target Price | $84.00 | ★ $138.75 |
| AVG Volume (30 Days) | ★ 975.0K | 949.2K |
| Earning Date | 04-22-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.80% | 1.02% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.22 | N/A |
| Revenue | ★ $4,021,000,000.00 | $1,992,713,000.00 |
| Revenue This Year | $3.56 | $15.97 |
| Revenue Next Year | $3.55 | $5.15 |
| P/E Ratio | $51.90 | ★ N/A |
| Revenue Growth | ★ 4.06 | N/A |
| 52 Week Low | $46.75 | $100.18 |
| 52 Week High | $81.00 | $139.67 |
| Indicator | TNL | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 39.55 | 55.48 |
| Support Level | $60.96 | $117.57 |
| Resistance Level | $65.49 | $134.84 |
| Average True Range (ATR) | 1.86 | 4.43 |
| MACD | -0.08 | -0.36 |
| Stochastic Oscillator | 33.48 | 61.83 |
Travel+Leisure Co is a membership and leisure travel company. It provides hospitality services and travel products. The company operates in the segments of Vacation Ownership, which is the key revenue-driving segment, develops, markets and sells vacation ownership interests (VOIs) to individual consumers, provides consumer financing in connection with the sale of VOIs, and provides property management services at resorts, and Travel and Membership which operates a variety of travel businesses, including two vacation exchange brands, Vacation Ownership and Travel and Membership The majority of the revenue is earned from the United States.
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.